Camlin Fine Sciences Limited · NSE:CAMLINFINE
Camlin Fine Sciences — Q1 FY27 Earnings Presentation
25 slides from Camlin Fine Sciences's earnings presentation, August 2026
Slide 1: Blending Strength. Building the Hive.
BLENDING STRENGTH. BUILDING THE HIVE. Camlin Fine Sciences Limited Investor Presentation – August 2026
Slide 2: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 3: Q1FY27 Financial Highlights
Q1FY27 Financial Highlights
Slide 4: Q1FY27 Financial Highlights – Continuing Operations
Q1FY27 Financial Highlights – Continuing Operations Revenue (Rs. In Mn) Operational EBITDA (Rs. In Mn) +28% 5,199 203 212 4,248 176 4,077 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 EBITDA Margin % PAT (Rs. In Mn) 4.98% 5.00% 10 3.40% -32 -318 Q1 FY26 Q4 FY26 Q1 FY27 On Consolidated Basis *EBITD
Slide 5: Highest Ever Quarterly Revenue
Highest Ever Quarterly Revenue Financial Performance Operating Environment Outlook — FY27 • Revenue at Rs 5,199 mn, up 27.5% YoY • Continued impact due to higher raw • Blends: Growth momentum to • Gross margin at 41.2% (48.5% in Q4 material prices continue across all geographies. Vitafor FY26) on hi
Slide 6: Segmental Highlights – Q1FY27
Segmental Highlights – Q1FY27 Specialty Ingredients Aroma Performance Chemicals & Others STRAIGHTS BLENDS ₹774 ₹1,749 ₹927 ₹3,086 Revenue Revenue Revenue Revenue ₹4,013 6.35% (4.37)% (2.54)% Total Revenue EBITDA EBITDA EBITDA Key Highlights Key Highlights Key Highlights ▪ Attractive growth markets a
Slide 7: Operational Revenue Breakup
Operational Revenue Breakup Specialty Ingredients (Rs. In Mn) Specialty Ingredients (Rs. In Mn) Total Specialty Ingredients (Rs. In Mn) (Straights) (Value added blends) 300 263 255 +41% +35% +37% 927 3,086 4,013 2,728 3,390 656 662 2,280 2,936 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26
Slide 8: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement From Continuing Operations Particulars (Rs. In Mn) Q1 FY27 Q1 FY26 Q4 FY26 FY26 Revenue from Operation 5,198.8 4,077.2 4,248.1 17,233.1 Raw material consumption 3,056.8 2,256.9 2,187.9 9,224.5 Employee Cost 734.3 567.4 659.3 2,439.0 Other expenses 1,314.9 1,050.0
Slide 9: Company Overview
Company Overview
Slide 10: Company Overview
Company Overview Catering Diverse Industries Among Global Leaders In the Manufacturing of Antioxidants Food & Beverage Animal Nutrition Pet Food Pharmaceuticals & Pharma Petrochemicals Dyes & Pigments Preferred Partner High Quality & Wide Range Intermediates For Customized Shelf-Life Solutions Vanil
Slide 11: From Manufacturing to Global Partnerships
From Manufacturing to Global Partnerships 1 Manufacturing Backbone India | Brazil | Mexico | France | Belgium Scale. Reliability. Consistency. 2 Core production hubs anchor the network, ensuring uninterrupted supply and quality. Innovation Close to Market Americas | Europe | Asia Co-create. Customiz
Slide 12: Product Highlights
Product Highlights FY26 Sales%*# Key Products End User Industries Key Brands › TBHQ › Pet Food › Animal Feed Mills Straights 18% › BHA › Livestock Nutrition › Biodiesel › Ascorbyl palmitate (ASP) › Food & Beverages › Aquaculture & Fishmeal › Fish Meal › Rendering Specialty Ingredients › 200+ custom
Slide 13: 1. a. Speciality Ingredients - Straights
1. a. Speciality Ingredients - Straights Key Products Key Brands TBHQ BHA Ascorbyl Palmitate Highly effective antioxidant Widely used antioxidant to Fat-soluble antioxidant that for protection against preserve quality and extend helps maintain color, flavor oxidative degradation. shelf life. and nut
Slide 14: 1. b. Speciality Ingredients – Value Added Blends
1. b. Speciality Ingredients – Value Added Blends Key Products Key Brands ▪ 200+ custom formulations, encompassing both traditional and natural solutions (forward- integrated antioxidant blends) ▪ Forward-integrated blends (TBHQ, BHA, BHT, ASP) effectively extend shelf life and prevent food/feed los
Slide 15: Expanding Global Reach in Blends
Expanding Global Reach in Blends Vitafor ▪ TRANSACTION SNAPSHOT ▪ BUSINESS PROFILE ▪ STRATEGIC VALUE PRODUCT / APPLICATION FOCUS ▪ 100% stake acquired ▪ Animal-feed ingredient ▪ Strengthens European & manufacturer and trader African reach Animal feed ingredients ▪ Cash consideration: €1 Mn ▪ Located
Slide 16: 2. Aroma Chemicals
2. Aroma Chemicals Key Products Vanillin Ethyl Vanillin Vanillin Ex-Clove Adorr vanillin range is Manufacture Methyl Vanillin Manufacture Ethyl Vanillin manufactured inhouse ensuring under Vanesse serving under Evanil serving multiple consistent quality, reliable supply, multiple industries industri
Slide 17: 3. Performance Chemicals & Others
3. Performance Chemicals & Others Key Products HQ Derivatives Catechol Derivatives › Chloranil › TBHQ › 4 TBC › Guaiacol › MEHQ › PDMB › Guethol › 1, 2MDB › HQEE › CME › Veratrole Key End User Industries Petrochemicals Dyes & Pigments Acrylates Agrochemicals Electroplating Pharmaceuticals Polymers P
Slide 18: Strategic Focus Areas across Segments
Strategic Focus Areas across Segments 1. Speciality Ingredients (Straights + Blends + Vitafor + Vinpai) 2. Aroma Chemicals 3. Performance Chemicals & Others AMEA Region America Region ▪ Deepened partnerships with key accounts ▪ Portfolio Expansion - Expand ▪ Accelerate towards Speciality ▪ Specialit
Slide 19: ESG
ESG Environmental • Transitioned from periodic monitoring to real-time environmental visibility through online installations, infrastructure upgrades • Undertook comprehensive thermal insulation program to minimize heat loss and optimize energy Social • Completely renovated the Occupational Health C
Slide 20: Board of Directors
Board of Directors › Over three decades of experience in pharmaceuticals and › Managing Director of the MJ Group with over three decades of specialty chemical products including business planning, Ashish Dandekar Amol Shah experience covering human healthcare, F&F compounds, plant information system
Slide 21: Senior Management Team
Senior Management Team Ashish Dandekar › Over three decades of experience in pharmaceuticals and specialty chemical products including business planning, information systems, research & Chairman & Managing Director development, product development, and marketing › Holds a BA in Economics and Managem
Slide 22: Historical Financial Highlights
Historical Financial Highlights
Slide 23: Historical Financial Highlights
Historical Financial Highlights Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 10.8% 12.7% 7.0% 9.3% 3.67% Margin 16,928 17,868 604 16,816 16,131 2,131 1,574 235 398 14,121 1,134 755 651 551 1,528 -315 656 14,131 16,287 17,233 2,160 1,790 -1,804 1,069 -2,232 2,000 641 635 -656 -586 -413 -1,0
Slide 24: Operational Revenue Break-up
Operational Revenue Break-up Specialty Ingredients (Rs. In Mn) Specialty Ingredients (Rs. In Mn) Total Specialty Ingredients (Rs. In Mn) (Straights) (Value added blends) 13,116 12,356 11,585 4,576 9,973 4,111 8,612 9,679 3,812 3,744 7,253 7,980 3,143 5,103 4,168 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY
Slide 25: Thank You !
Thank You ! Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Santosh Parab- CFO Email – [email protected] [email protected] www.camlinfs.com www.camlinfs.com http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Shrikant San